![]() | Up a level |
Journal Article
Shimabukuro-Vornhagen, Alexander, Garcia-Marquez, Maria, Fischer, Rieke N., Iltgen-Breburda, Juliane, Fiedler, Anne, Wennhold, Kerstin ORCID: 0000-0001-5539-7226, Rappl, Gunter, Abken, Hinrich, Lehmann, Clara, Herling, Marco, Wolf, Dominik, Faetkenheuer, Gerd, Rubbert-Roth, Andrea, Hallek, Michael, Theurich, Sebastian
ORCID: 0000-0001-5706-8258 and von Bergwelt-Baildon, Michael
(2017).
Antigen-presenting human B cells are expanded in inflammatory conditions.
J. Leukoc. Biol., 101 (2).
S. 577 - 588.
HOBOKEN:
WILEY.
ISSN 1938-3673
Wennhold, Kerstin ORCID: 0000-0001-5539-7226, Weber, Tanja M., Klein-Gonzalez, Nela, Thelen, Martin
ORCID: 0000-0002-2785-9726, Garcia-Marquez, Maria, Chakupurakal, Geothy, Fiedler, Anne, Schloesser, Hans A., Fischer, Rieke, Theurich, Sebastian
ORCID: 0000-0001-5706-8258, Shimabukuro-Vornhagen, Alexander and von Bergwelt-Baildon, Michael
(2017).
CD40-activated B cells induce anti-tumor immunity in vivo.
Oncotarget, 8 (17).
S. 27740 - 27754.
ORCHARD PARK:
IMPACT JOURNALS LLC.
ISSN 1949-2553
Lechner, Axel, Schloesser, Hans, Rothschild, Sacha I., Thelen, Martin ORCID: 0000-0002-2785-9726, Reuter, Sabrina, Zentis, Peter, Shimabukuro-Vornhagen, Alexander, Theurich, Sebastian
ORCID: 0000-0001-5706-8258, Wennhold, Kerstin
ORCID: 0000-0001-5539-7226, Garcia-Marquez, Maria, Tharun, Lars, Quaas, Alexander, Schauss, Astrid, Isensee, Joerg
ORCID: 0000-0002-3390-0051, Hucho, Tim
ORCID: 0000-0002-4147-9308, Huebbers, Christian
ORCID: 0000-0002-2934-1218, von Bergwelt-Baildon, Michael and Beutner, Dirk
(2017).
Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
Oncotarget, 8 (27).
S. 44418 - 44434.
ORCHARD PARK:
IMPACT JOURNALS LLC.
ISSN 1949-2553
Wennhold, Kerstin ORCID: 0000-0001-5539-7226, Thelen, Martin
ORCID: 0000-0002-2785-9726, Schloesser, Hans Anton, Haustein, Natalie, Reuter, Sabrina, Garcia-Marquez, Maria, Lechner, Axel, Kobold, Sebastian, Rataj, Felicitas, Utermoehlen, Olaf, Chakupurakal, Geothy, Theurich, Sebastian
ORCID: 0000-0001-5706-8258, Hallek, Michael, Abken, Hinrich, Shimabukuro-Vornhagen, Alexander and von Bergwelt-Baildon, Michael
(2017).
Using Antigen-Specific B Cells to Combine Antibody and T Cell-Based Cancer Immunotherapy.
Cancer Immunol. Res., 5 (9).
S. 730 - 744.
PHILADELPHIA:
AMER ASSOC CANCER RESEARCH.
ISSN 2326-6074
Schloesser, Hans A., Drebber, Uta, Kloth, Michael, Thelen, Martin ORCID: 0000-0002-2785-9726, Rothschild, Sacha I., Haase, Simon, Garcia-Marquez, Maria, Wennhold, Kerstin
ORCID: 0000-0001-5539-7226, Berlth, Felix
ORCID: 0000-0002-3780-0728, Urbanski, Alexander, Alakus, Hakan, Schauss, Astrid, Shimabukuro-Vornhagen, Alexander, Theurich, Sebastian
ORCID: 0000-0001-5706-8258, Warnecke-Ebertz, Ute, Stippel, Dirk L., Zippelius, Alfred, Buettner, Reinhard, Hallek, Michael, Hoelscher, Arnulf H., Zander, Thomas, Moenig, Stefan P. and von Bergwelt-Baildon, Michael
(2016).
Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma.
OncoImmunology, 5 (5).
PHILADELPHIA:
TAYLOR & FRANCIS INC.
ISSN 2162-402X
Theurich, Sebastian ORCID: 0000-0001-5706-8258, Schlaak, Max, Steguweit, Harold, Heukamp, Lukas C., Wennhold, Kerstin
ORCID: 0000-0001-5539-7226, Kurschat, Peter, Rabenhorst, Anja, Hartmann, Karin
ORCID: 0000-0002-4595-8226, Schloesser, Hans, Shimabukuro-Vornhagen, Alexander
ORCID: 0000-0002-2351-7294, Holtick, Udo, Hallek, Michael, Stadler, Rudolf and von Bergwelt-Baildon, Michael
(2016).
Targeting Tumor-Infiltrating B Cells in Cutaneous T-Cell Lymphoma.
J. Clin. Oncol., 34 (12).
S. E110 - 7.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
Gonzalez, Nela Klein, Wennhold, Kerstin ORCID: 0000-0001-5539-7226, Balkow, Sandra, Kondo, Eisei
ORCID: 0000-0003-0995-9405, Boelck, Birgit, Weber, Tanja, Garcia-Marquez, Maria, Grabbe, Stephan, Bloch, Wilhelm, von Bergwelt-Baildon, Michael and Shimabukuro-Vornhagen, Alexander
ORCID: 0000-0002-2351-7294
(2015).
In vitro and in vivo imaging of initial B-T-cell interactions in the setting of B-cell based cancer immunotherapy.
OncoImmunology, 4 (9).
PHILADELPHIA:
TAYLOR & FRANCIS INC.
ISSN 2162-402X
Shimabukuro-Vornhagen, Alexander ORCID: 0000-0002-2351-7294, Schloesser, Hans A., Gryschok, Luise, Malcher, Joke, Wennhold, Kerstin
ORCID: 0000-0001-5539-7226, Garcia-Marquez, Maria, Herbold, Till, Neuhaus, Laura S., Becker, Hans J., Fiedler, Anne, Scherwitz, Pascal, Koslowsky, Thomas, Hake, Roland, Stippel, Dirk L., Hoelscher, Arnulf H., Eidt, Sebastian, Hallek, Michael, Theurich, Sebastian
ORCID: 0000-0001-5706-8258 and von Bergwelt-Baildon, Michael S.
(2014).
Characterization of tumor-associated B-cell subsets in patients with colorectal cancer.
Oncotarget, 5 (13).
S. 4651 - 4665.
ORCHARD PARK:
IMPACT JOURNALS LLC.
ISSN 1949-2553
Shimabukuro-Vornhagen, Alexander ORCID: 0000-0002-2351-7294, Zoghi, Shahram, Liebig, Tanja M., Wennhold, Kerstin
ORCID: 0000-0001-5539-7226, Chemitz, Jens, Draube, Andreas, Kochanek, Matthias, Blaschke, Florian, Pallasch, Christian, Holtick, Udo, Scheid, Christof, Theurich, Sebastian
ORCID: 0000-0001-5706-8258, Hallek, Michael and von Bergwelt-Baildon, Michael S.
(2014).
Inhibition of Protein Geranylgeranylation Specifically Interferes with CD40-Dependent B Cell Activation, Resulting in a Reduced Capacity To Induce T Cell Immunity.
J. Immunol., 193 (10).
S. 5294 - 5306.
BETHESDA:
AMER ASSOC IMMUNOLOGISTS.
ISSN 1550-6606
Garcia-Marquez, Maria A., Shimabukuro-Vornhagen, Alexander ORCID: 0000-0002-2351-7294, Theurich, Sebastian
ORCID: 0000-0001-5706-8258, Kochanek, Matthias, Weber, Tanja, Wennhold, Kerstin
ORCID: 0000-0001-5539-7226, Dauben, Alexandra, Dzionek, Andrzej, Reinhard, Claudia and von Bergwelt-Baildon, Michael
(2014).
A multhnerized form of recombinant human CD40 ligand supports long-term activation and proliferation of B cells.
Cytotherapy, 16 (11).
S. 1537 - 1545.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1477-2566
Garcia-Marquez, Maria A., Wennhold, Kerstin ORCID: 0000-0001-5539-7226, Draube, Andreas and von Bergwelt-Baildon, Michael
(2012).
Results of a Phase II clinical trial with Id-protein-loaded dendritic cell vaccine in multiple myeloma: encouraging or discouraging?
Immunotherapy, 4 (10).
S. 991 - 995.
LONDON:
FUTURE MEDICINE LTD.
ISSN 1750-743X